Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CAPTOPRIL | 25MG | TABLET | Resolved | 2019-10-31 | 2020-01-09 | 97611 |
FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-11-21 | 2020-01-09 | 99441 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Avoided shortage | 2019-11-21 | 2020-07-10 | 99453 |
TEVA-METOPROLOL | 25MG | TABLET | Resolved | 2019-12-05 | 2021-09-30 | 100308 |
TEVA-ATENOLOL | 25MG | TABLET | Actual shortage | 2020-01-24 | 2020-01-24 | 104310 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-03-06 | 2020-03-26 | 107970 |
TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2020-03-12 | 2020-03-26 | 108593 |
TEVA-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-03-26 | 2021-04-15 | 109632 |
TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110697 |
TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110700 |
TEVA-SILDENAFIL | 25MG | TABLET | Resolved | 2020-05-01 | 2020-05-08 | 113749 |
TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2020-05-08 | 2020-08-21 | 114439 |
ACT QUETIAPINE | 25MG | TABLET | Resolved | 2020-08-06 | 2021-01-07 | 121852 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-08-13 | 2020-11-07 | 122217 |
TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2020-08-27 | 2020-09-17 | 123087 |
TEVA-SERTRALINE | 25MG | CAPSULE | Resolved | 2020-11-12 | 2021-03-18 | 128330 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-11-12 | 2021-01-28 | 128339 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-12-17 | 2021-01-21 | 130296 |
ACT EXEMESTANE | 25MG | TABLET | Resolved | 2021-02-05 | 2021-04-01 | 133470 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2021-02-25 | 2021-05-06 | 134749 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |